Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ranolazine (ranexa) (1 trial)
ropivacaine (naropin) (1 trial)
Atrial Fibrillation (Phase 3)
Trials (2 total)
Trial APIs (2 total)